ALS

Ni2o will use Nurosene’s NetraAI technology to accelerate their research into neurodegenerative disease treatments. 

TORONTO, Nov. 29, 2021 /CNW/ – Nurosene Health Inc. (“Nurosene” or the “Company”) (CSE: MEND) (Frankfurt: 8TV) (OTC: MNNDF), a healthtech company focused on building a generation of healthier brains, today announced that